He H - Search Results

1

Synthetic high-density lipoproteins loaded with an antiplatelet drug for efficient inhibition of thrombosis in mice.

He H, Adili R, Liu L, Hong K, Holinstat M, Schwendeman A. He H, et al. Sci Adv. 2020 Dec 4;6(49):eabd0130. doi: 10.1126/sciadv.abd0130. Print 2020 Dec. Sci Adv. 2020. PMID: 33277254 Free PMC article.

2

Artificial high-density lipoprotein-mimicking nanotherapeutics for the treatment of cardiovascular diseases.

He H, Hong K, Liu L, Schwendeman A. He H, et al. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Nov;13(6):e1737. doi: 10.1002/wnan.1737. Epub 2021 Jul 14. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021. PMID: 34263549 Review.

3

Nanodisc delivery of liver X receptor agonist for the treatment of diabetic nephropathy.

He H, Halseth TA, Mei L, Shen C, Liu L, Schwendeman A. He H, et al. J Control Release. 2022 Aug;348:1016-1027. doi: 10.1016/j.jconrel.2022.06.029. Epub 2022 Jul 4. J Control Release. 2022. PMID: 35750132

4

Development of activated endothelial targeted high-density lipoprotein nanoparticles.

Yu M, Hong K, Adili R, Mei L, Liu L, He H, Guo Y, Chen YE, Holinstat M, Schwendeman A. Yu M, et al. Among authors: he h. Front Pharmacol. 2022 Aug 29;13:902269. doi: 10.3389/fphar.2022.902269. eCollection 2022. Front Pharmacol. 2022. PMID: 36105190 Free PMC article.

5

Survey of Clinical Translation of Cancer Nanomedicines-Lessons Learned from Successes and Failures.

He H, Liu L, Morin EE, Liu M, Schwendeman A. He H, et al. Acc Chem Res. 2019 Sep 17;52(9):2445-2461. doi: 10.1021/acs.accounts.9b00228. Epub 2019 Aug 19. Acc Chem Res. 2019. PMID: 31424909 Review.

6

Overview of Humira® Biosimilars: Current European Landscape and Future Implications.

Coghlan J, He H, Schwendeman AS. Coghlan J, et al. Among authors: he h. J Pharm Sci. 2021 Apr;110(4):1572-1582. doi: 10.1016/j.xphs.2021.02.003. Epub 2021 Feb 5. J Pharm Sci. 2021. PMID: 33556387 Free PMC article. Review.

7

Advances on Non-Genetic Cell Membrane Engineering for Biomedical Applications.

Liu L, He H, Liu J. Liu L, et al. Among authors: he h. Polymers (Basel). 2019 Dec 5;11(12):2017. doi: 10.3390/polym11122017. Polymers (Basel). 2019. PMID: 31817418 Free PMC article. Review.

8

Synergetic Effect of rHDL and LXR Agonist on Reduction of Atherosclerosis in Mice.

Morin EE, Guo Y, He H, Yuan W, Souery WN, Fawaz MV, Chen YE, Schwendeman A. Morin EE, et al. Among authors: he h. Front Pharmacol. 2020 Dec 16;11:513031. doi: 10.3389/fphar.2020.513031. eCollection 2020. Front Pharmacol. 2020. PMID: 33390931 Free PMC article.

9

Hyaluronic acid-decorated reconstituted high density lipoprotein targeting atherosclerotic lesions.

Liu L, He H, Zhang M, Zhang S, Zhang W, Liu J. Liu L, et al. Among authors: he h. Biomaterials. 2014 Sep;35(27):8002-14. doi: 10.1016/j.biomaterials.2014.05.081. Epub 2014 Jun 16. Biomaterials. 2014. PMID: 24947229

10

Suppression of Remodeling Behaviors with Arachidonic Acid Modification for Enhanced in vivo Antiatherogenic Efficacies of Lovastatin-loaded Discoidal Recombinant High Density Lipoprotein.

He H, Zhang M, Liu L, Zhang S, Liu J, Zhang W. He H, et al. Pharm Res. 2015 Oct;32(10):3415-31. doi: 10.1007/s11095-015-1719-x. Epub 2015 Jun 4. Pharm Res. 2015. PMID: 26040661

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,298 results

Search Page

Filters